In a report released today, Jason Butler from JMP Securities reiterated a Hold rating on Cortexyme (CRTX – Research Report). The company's shares closed last Tuesday at $4.65, close to its 52-week low of $3.79. According to TipRanks.com, Butler has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -4.9% and a 36.8% success rate. Butler covers the Healthcare sector, focusing on stocks such as Applied Molecular Transport, ACADIA Pharmaceuticals, and Aquestive Therapeutics. Currently, the analyst consensus on Cortexyme is a Moderate Buy with an average price target of $21.00.
https://www.tipranks.com/news/blurbs/cortexyme-crtx-gets-a-hold-rating-from-jmp-securities?utm_source=advfn.com&utm_medium=referral
Quince Therapeutics (NASDAQ:QNCX)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more Quince Therapeutics Charts.
Quince Therapeutics (NASDAQ:QNCX)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more Quince Therapeutics Charts.